학술논문

Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial
Document Type
Journal
Source
DIABETES OBESITY & METABOLISM; NOV 14 2022, 11p.
Subject
Language
English
ISSN
14631326